Enterprise Value
N/A
Mon, 01 Jan 0001 00:00:00 GMT
Summary
- NLTX enterprise value is not available.
Performance
NLTX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
NLTX Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| 6 m6 months | - | - | - |
| 1 y1 year | - | - | - |
| 5 y5 years | - | - | - |
NLTX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | ||||
| 6 m | 6-month | ||||
| 1 y | 1-year | ||||
| 3 y | 3-year | $22 M | -$76 M | ||
| 5 y | 5-year | $536 M | -$76 M | ||
| alltime | all time | $536 M | -$76 M |
Neoleukin Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2023 | -$6.33 M(+54.1%) |
| 2022 | -$4.11 M(-105.5%) |
| 2021 | $75.16 M(-81.9%) |
| 2020 | $414.53 M(+27.1%) |
| 2019 | $326.25 M(-1351.4%) |
| Date | Value |
|---|---|
| 2018 | -$26.07 M(-111.6%) |
| 2017 | $224.03 M(-36.8%) |
| 2016 | $354.48 M(+102.2%) |
| 2015 | $175.29 M(+168.4%) |
| 2014 | $65.31 M |
FAQ
- What is the all time high enterprise value for Neoleukin Therapeutics?
What is the all time high enterprise value for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high enterprise value is $535.66 M